Compile Data Set for Download or QSAR
Report error Found 520 Enz. Inhib. hit(s) with all data for entry = 85
TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163287(US9687479, 206 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163283(US9687479, 204 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163282(US9687479, 203 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163281(US9687479, 202 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163280(US9687479, 201 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163279(US9687479, 200 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163298(US9687479, 214 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163297(US9687479, 213 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163296(US9687479, 212 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163295(US9687479, 211 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163293(US9687479, 210 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163292(US9687479, 209 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163291(US9687479, 208 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163290(US9687479, 207 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163304(US9687479, 218 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163302(US9687479, 217 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163301(US9687479, 216 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163300(US9687479, 215 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163333(US9687479, 238 3-[5-(benzylamino)-1-[(furan-2-yl)c...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163345(US9687479, 246 3-1-[(2-chlorophenyl)carbonyl]-5-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163343(US9687479, 245 3-1-[(2-chlorophenyl)carbonyl]-5-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163341(US9687479, 244 3-1-[(2-chlorophenyl)carbonyl]-5-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163340(US9687479, 243 3-1-[(2-chlorophenyl)carbonyl]-5-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163338(US9687479, 242 3-1-[(2-chlorophenyl)carbonyl]-5-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163337(US9687479, 241 3-1-[(2-aminophenyl)carbonyl]-5-[(5...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163356(US9687479, 254 3-1-[(4-tert-butylphenyl)carbonyl]-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163355(US9687479, 253 3-1-[(4-tert-butylphenyl)carbonyl]-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163353(US9687479, 252 3-1-[(2-chlorophenyl)carbonyl]-5-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163341(US9687479, 244 3-1-[(2-chlorophenyl)carbonyl]-5-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163340(US9687479, 243 3-1-[(2-chlorophenyl)carbonyl]-5-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163349(US9687479, 249 3-1-[(2-chlorophenyl)carbonyl]-5-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163348(US9687479, 248 3-1-[(2-chlorophenyl)carbonyl]-5-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163346(US9687479, 247 3-1-[(2-chlorophenyl)carbonyl]-5-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163367(US9687479, 262 tert-butyl 2-[3-(5-[(5-chlorothioph...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163366(US9687479, 261 tert-butyl 2-[3-(5-[(5-chlorothioph...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163363(US9687479, 259 ethyl 2-[3-(5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163362(US9687479, 258 ethyl 2-[3-(5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163360(US9687479, 257 ethyl 2-[3-(5-[(5-chlorothiophen-2-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163373(US9687479, 265 1-[(5-[(5-chlorothiophen-2-yl)methy...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM163369(US9687479, 263 tert-butyl 2-[3-(5-[(5-chlorothioph...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Verseon

US Patent
LigandPNGBDBM163346(US9687479, 247 3-1-[(2-chlorophenyl)carbonyl]-5-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human KLKB1 protein was obtained from Enzyme Research Labs. The chromogenic substrate S-2302 was obtained from DiaPharma. KLKB1 was assayed in buffer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Verseon

US Patent
LigandPNGBDBM163508(US9687479, 22 N-[(5-chlorothiophen-2-yl)methyl]-1-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human KLKB1 protein was obtained from Enzyme Research Labs. The chromogenic substrate S-2302 was obtained from DiaPharma. KLKB1 was assayed in buffer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Verseon

US Patent
LigandPNGBDBM163599(US9687479, 364 3-(5-[(5-chlorothiophen-2-yl)methyl...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human KLKB1 protein was obtained from Enzyme Research Labs. The chromogenic substrate S-2302 was obtained from DiaPharma. KLKB1 was assayed in buffer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Verseon

US Patent
LigandPNGBDBM164171(US9687479, 388 N-[(5-chlorothiophen-2-yl)methyl]-1...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human KLKB1 protein was obtained from Enzyme Research Labs. The chromogenic substrate S-2302 was obtained from DiaPharma. KLKB1 was assayed in buffer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Verseon

US Patent
LigandPNGBDBM164103(US9687479, 383 N-[(5-chlorofuran-2-yl)methyl]-1-[(...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human KLKB1 protein was obtained from Enzyme Research Labs. The chromogenic substrate S-2302 was obtained from DiaPharma. KLKB1 was assayed in buffer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162368(US9687479, 5 3-(5-[(5-chlorothiophen-2-yl)methyl]a...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162367(US9687479, 4 3-(5-[(5-chlorothiophen-2-yl)methyl]a...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162366(US9687479, 3 3-(5-[(5-chlorothiophen-2-yl)methyl]a...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162375(US9687479, 29 1-[(2-chlorophenyl)methyl]-3-(5-[(5-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162374(US9687479, 28 1-[(2-chlorophenyl)methyl]-3-(5-[(5-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

Displayed 1 to 50 (of 520 total ) | Next | Last >>
Jump to: